Evidence map›Paper›PMID 40788471›Full record

ArticleCellular oncology (Dordrecht, Netherlands)2025

The m

Yifan Liu, Gege Liu, Xuanlin Wang, Xueru Zhang, Junlu Wu, Yaran Li, Yao Lu, Ce Shi, Feng Ye, Ruixin Sun

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Cellular oncology (Dordrecht, Netherlands), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Yifan Liu *Department of Laboratory Medicine, Shanghai Tongji Hospital, School of Medicine, Tongji University, Shanghai, 200065, China.
Gege Liu *Department of Laboratory Medicine, Shanghai Tongji Hospital, School of Medicine, Tongji University, Shanghai, 200065, China.
Xuanlin Wang *Department of Laboratory Medicine, Shanghai Tongji Hospital, School of Medicine, Tongji University, Shanghai, 200065, China.
Xueru Zhang *Department of Laboratory Medicine, Shanghai Tongji Hospital, School of Medicine, Tongji University, Shanghai, 200065, China.
Junlu WuDepartment of Laboratory Medicine, Shanghai Tongji Hospital, School of Medicine, Tongji University, Shanghai, 200065, China.
Yaran LiDepartment of Laboratory Medicine, Shanghai Tongji Hospital, School of Medicine, Tongji University, Shanghai, 200065, China.
Yao LuInternational Office, Tongji Hospital, School of Medicine, Tongji University, Shanghai, 200065, P.R. China.
Ce ShiDepartment of Laboratory Medicine, Ruijin Hospital, Shanghai JiaoTong University School of Medicine, Shanghai, China. shice1602@163.com.
Feng YeDepartment of General Surgery, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200032, China. yefengsurgeon@163.com.
Ruixin SunDepartment of Laboratory Medicine, Shanghai Tongji Hospital, School of Medicine, Tongji University, Shanghai, 200065, China. qingshuiqiuqian@126.com.

Funding

National Natural Science Foundation of China 82304365Shanghai Municipal Health and Health Commission 20234Y0193Shanghai 'Rising Stars of Medical Talents' Youth Development Program-Clinical Laboratory Practitioner Program 2023-JY
6 · The paper itself

Abstract

backgroundWhile immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy, their efficacy in gastric cancer (GC) remains limited, underscoring the need for mechanistic biomarkers of immune evasion.

methodsWe analyzed m

resultsHigh-m

conclusionOur study unveils m CLINICAL TRIAL NUMBER: Not applicable.

Indexed as

NFATC Transcription FactorsStomach NeoplasmsT-LymphocytesAnimalsCell Line, TumorHepatitis A Virus Cellular Receptor 2HumansImmune Checkpoint InhibitorsMiceSignal TransductionT-Cell ExhaustionTumor MicroenvironmentHepatitis A Virus Cellular Receptor 2Immune Checkpoint InhibitorsNFATC Transcription FactorsGastric cancerImmune checkpoint inhibitorsm1A modificationSFRP2T cell exhaustion

Identifiers

PMID40788471
PMCPMC12528264

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.